The agency is considering whether to limit the indications of Keytruda, Opdivo, and Tevimbra to PD-L1-positive patients amid testing uncertainties.

Pregnant women who do not get enough sleep may be at higher risk of having children with neurodevelopmental delays, a new ...

Rheumatologists and lab specialists generally support consumers' ability to access tests without a doctor's order, but they remain aware of the possible harms that can come with practice.

We recently compiled a list of the 10 Undervalued Wide Moat Stocks to Buy According to Analysts. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the ...

Pharmaceutical manufacturing jobs are on the rise in Lakewood as companies like Renaissance Lakewood expand its operations.

Siemens Digital Industries Software has updated its Simcenter Testlab suite, focusing on increased collaboration, enhanced ...

Phytopathological Disease Diagnostics Market is set to reach USD 163.4 million by 2034 Sales are poised to rise at a 4.5% ...

The days of broad stomach cancer labels for PD-1 inhibitors appear to be numbered.  | The days of broad stomach cancer labels ...

The phase III KEYFORM-007 study, evaluating Merck's Keytruda plus favezelimab for treating metastatic colorectal cancer, ...

Merck & Co. has picked up options on two Evaxion vaccine candidates, paying $3.2 million and dangling more than $1 billion in ...

Merck's Phase III KEYFORM-007 trial, testing a combination of favezelimab and Keytruda, failed to meet its primary endpoint ...

With generative AI for ETL and data pipelines, data engineers, analysts, and scientists can spend more time solving business ...